Division of Neurodegenerative Disorders, St. Boniface Research Centre, Winnipeg, MB, R2H 2A6, Canada.
Brain Struct Funct. 2010 Jul;215(1):29-36. doi: 10.1007/s00429-010-0271-z. Epub 2010 May 29.
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that has been characterized by gross cortical atrophy, cellular neurodegeneration, reactive gliosis, and the presence of microscopic extracellular amyloid plaques and intracellular neurofibrillary tangles. Earlier diagnoses of AD would be in the best interest of managing the patient and would allow for earlier therapeutic intervention. By measuring the apparent diffusion coefficient (ADC) using diffusion-weighted imaging (DWI), a type of magnetic resonance imaging (MRI), one can quantify alterations in water diffusivity resulting from microscopic structural changes in the cell at early stages that are associated with pathophysiological processes of brain injury and/or disease progression. Whether or not this methodology is useful for AD is a question under examination. For example, DWI in suspected AD patients has shown increases in mean ADC values in the hippocampus and diminished diffusion anisotropy in the posterior white matter. However, in some cases, hippocampal ADC values appear not to change in AD patients. Moreover, to our knowledge, all DWI studies in suspected AD patients to date are technically incomplete in experimental design, because corresponding histological sections demonstrating actual plaque deposition are lacking and so it is not clear that ADC changes actually correspond to plaque deposition. In our study, we used DWI in the TgCRND8 transgenic model of Alzheimer's disease in conjunction with histological techniques and found robust plaque deposition in the transgenic strain in older animals (12-16 months old). However, we did not find statistically significant changes (p > 0.05) in ADC values (although ADC values in TgCRND8 mice did decrease in all regions examined) in mice 12-16 months old. Collectively, recent results from human studies and in rodent AD transgenic models support our findings and suggest that amyloid beta plaque load is not likely the major or primary component contributing to diffusional changes, if they occur.
阿尔茨海默病(AD)是一种进行性神经退行性疾病,其特征为皮质广泛萎缩、细胞神经退行性变、反应性神经胶质增生以及微观细胞外淀粉样斑块和细胞内神经原纤维缠结的存在。早期诊断 AD 将有利于患者的管理,并允许更早的治疗干预。通过使用磁共振成像(MRI)的扩散加权成像(DWI)测量表观扩散系数(ADC),可以定量测量由于细胞微观结构变化导致的水扩散率的变化,这些变化与脑损伤和/或疾病进展的病理生理过程有关。这种方法是否对 AD 有用,这是一个正在研究的问题。例如,在疑似 AD 患者中进行的 DWI 显示,海马体的平均 ADC 值增加,后白质的扩散各向异性降低。然而,在某些情况下,AD 患者的海马体 ADC 值似乎没有变化。此外,据我们所知,迄今为止,所有疑似 AD 患者的 DWI 研究在实验设计上都不完全,因为缺乏显示实际斑块沉积的相应组织学切片,因此不清楚 ADC 变化是否与斑块沉积实际对应。在我们的研究中,我们在阿尔茨海默病的 TgCRND8 转基因模型中使用了 DWI 结合组织学技术,发现老年转基因品系中有大量斑块沉积(12-16 个月大)。然而,我们没有发现 ADC 值有统计学上的显著变化(p > 0.05)(尽管在所有检查的区域中,TgCRND8 小鼠的 ADC 值都降低了)。总之,来自人类研究和啮齿动物 AD 转基因模型的最新结果支持我们的发现,并表明如果发生扩散变化,淀粉样β斑块负荷不太可能是主要或主要成分。